We’re proud to announce that the eSense pilot program is now underway, bringing clinically validated sexual health support to women through participating clinics and early users across North America.

eSense is grateful to have received a grant from the National Vulvodynia Association Medical Research Fund to support proof-of-concept work exploring eSense as a potential treatment for provoked vestibulodynia (PVD).

We’re proud to share that eSense has been named Most Innovative Women’s Sexual Health Platform by Global Health & Pharma, an international publication highlighting excellence and innovation across the healthcare and life sciences sectors.

A newly published study in Cognitive Behaviour Therapy has found that eSense is effective in treating Sexual Interest/Arousal Disorder in women with a history of sexual assault—and may also reduce PTSD symptoms.

eSense Health has been selected to present at Life Science BC’s 10th annual Invest in BC Conference to be held on October 28 and 29th at the Vancouver Convention Centre West and sponsored by Lumira

eSense Health is proud to announce the publication of a pivotal randomized clinical trial in the peer-reviewed journal Behaviour Research & Therapy, validating the efficacy of its flagship product, eSense—a digital program designed to support